FdaApplication

ANDA 211835

Back to search

Identifiers

Properties

PropertyValue
applicant_nameTORRENT PHARMA INC
application_typeANDA
approval_date2020-10-21

Products (3)

ProductActive ingredientStrengthDosage form
APREPITANTAPREPITANT125MGCAPSULE;ORAL
APREPITANTAPREPITANT80MGCAPSULE;ORAL
APREPITANTAPREPITANT40MGCAPSULE;ORAL

3 products